J&J unit gains approval for clot-removal device in Europe

06/17/2013 | MassDevice.com (Boston) · MedGadget.com

Codman Neuro, which is part of Johnson & Johnson's DePuy Synthes business, has earned the CE mark in Europe for its Revive SE clot-removal system. The next-generation device, which comes with a new strut that reduces the force required to guide the system with a microcatheter, is used to treat acute ischemic stroke by restoring blood flow to the patient's brain.

View Full Article in:

MassDevice.com (Boston) · MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY